Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus

Vancomycin has been used as the last resort in the clinical treatment of serious Staphylococcus aureus infections. Vancomycin-intermediate S. aureus (VISA) was discovered almost two decades ago. Aside from the vancomycin-intermediate phenotype, VISA strains from the clinic or laboratory exhibited co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiwen, Peng, Huagang, Rao, Xiancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062060/
https://www.ncbi.nlm.nih.gov/pubmed/27790199
http://dx.doi.org/10.3389/fmicb.2016.01601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062060/
https://www.ncbi.nlm.nih.gov/pubmed/27790199
http://dx.doi.org/10.3389/fmicb.2016.01601

Ejemplares similares